Table:
begin	end	state
1	25	signal peptide
26	27	non-cytoplasmic
28	38	transmembrane
39	47	non-cytoplasmic
48	53	cytoplasmic
54	73	transmembrane
74	75	cytoplasmic
76	95	non-cytoplasmic
96	117	transmembrane
118	137	cytoplasmic
138	164	transmembrane
165	170	non-cytoplasmic
171	196	transmembrane
197	216	cytoplasmic
217	236	transmembrane
237	241	non-cytoplasmic
242	259	transmembrane
260	278	cytoplasmic
279	299	transmembrane
300	314	non-cytoplasmic
315	353	transmembrane
354	356	cytoplasmic
357	358	non-cytoplasmic
359	384	transmembrane
385	403	non-cytoplasmic
404	429	transmembrane
430	430	cytoplasmic

Input:
>WP_004303790.1 NCBI__GCF_000310185.1:WP_004303790.1
MTVGLLSLLAVLVLAFLRVPLAFALLSVSLGGIGVVMGWDVARSLVPMTISEAVFSYELA
VVPMFILMGNILARTGISDDLFRAANAFLGPVRGGLALSTMVTCAGFSAVCGSSLATAAT
MSKVAYPSMKRYGYSDALASATIAAGGTLGILIPPSIILMIYGILTQTNIGHLFVAGVVP
GLLGLLMYLLVIYAVARISPQDAPRGERTTMAEKLHALRGVWPFTLLFVLIIGGLYGKLF
TATEAAGMGAGLALILSMVQGRMSWQDFRHIFIETATTSVMLYSVLFGALLFAKLISFSG
LGEGILELFNQAGLGPWGTIVAILVVFLLLGCVMDSLAIILICVPLFVPILLAHGFDLVW
FGIIVVVVTEIALITPPIGMNVFVLKATLPHVRLGAIFRGLTPFIAIDLVRLALLVIFPS
ISLALVAFMK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server